Skip to content

Outcomes of A Novel Treatment Decision of Patients With Esophageal and Head and Neck Carcinoma Synchronously

Outcomes of a Novel Treatment Decision of Patients With Superficial Esophageal Carcinoma Synchronously Associated With Head and Neck Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03450447
Enrollment
20
Registered
2018-03-01
Start date
2018-03-10
Completion date
2020-05-07
Last updated
2018-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer Stage, Head and Neck Cancer

Keywords

Head and Neck Cancer, Esophageal Cancer, endoscopic submucosal dissection, quality of life, median survival time

Brief summary

To summarise the outcomes of a treatment decision of patients with superficial esophageal carcinoma synchronously associated with head and neck cancer, that is endoscopic treatment for the superficial esophageal carcinoma plus surgery of the head and neck carcinoma.

Detailed description

As a same risk factor, such as heavy drinking and smoking, patients with head and ncek carcinoma are always suffering from synchronous esophageal squamous cell carcinoma. Previous studies illustrated that many patients with multiple esophageal lesions of early stage. In clinical practice, those patients are treated by extensive surgical resection of total pharyngo-laryngo-esophagectomy plus free jejunum interposition or gastric tube, then followed by chemoradiotherapy as standard treatment, resulting in a low quality of life for the patients, and due to the above mentioned disadvantages, many patients with synchronous superficial esophageal squamous cell carcinoma and head and neck carcinoma refused the surgery treatment. Our aims is to summarize the the outcomes of endoscopic treatment for the superficial esophageal carcinoma plus surgery of head and neck carcinoma.

Interventions

None listed

Sponsors

Yanqing Li
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Patients with head and ncek carcinoma associated with synchronous superficial esophageal squamous cell carcinoma. 2. Patients agree to be treated with esophageal endoscopic submucosal dissection firstly, then accept surgery of head and neck carcinoma.

Exclusion criteria

1. Patients refuse a endoscopic submucosal dissection or surgery. 2. Patients with sever systemic disease, such as sever cardiopulmonary disease, renal failure and impaired blood coagulation. 3. Obstruction of the pharynx leading to a failure of insertion of endoscopy. 4. Patients with an advanced esophageal carcinoma evaluated by endoscopy.

Design outcomes

Primary

MeasureTime frameDescription
The first day of food intake of enrolled patientsAn average of 1weekThe first day of food intake after surgery of the head and neck carcinoma

Secondary

MeasureTime frameDescription
The relapse rate of the enrolled patientsan average of 2 yearsthe relapse rate of esophageal cancer or head and neck carcinoma respectively of the enrolled patients.
The hospital stay of enrolled patientsAn average of 1 month.The total hospital stay during the first hospitalization of the enrolled patients
The incidence of stenosisan average of 2 yearsThe average interval of the stenosis
The severity of stenosisan average of 2 yearsThe average diameter of the stenosis

Countries

China

Contacts

Primary ContactYanqing Li
liyanqing@sdu.edu.cn18678827666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026